Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Busulfan × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 54 Leukemia 48 Myelodysplastic Syndromes 46 Lymphoma 42 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Lymphoma, Non-Hodgkin 39 Hodgkin Disease 34 Multiple Myeloma 32 Leukemia, Lymphocytic, Chronic, B-Cell 29 Lymphoma, Mantle-Cell 23 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Follicular 23 Neoplasms, Plasma Cell 21 Congenital Abnormalities 21 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Myelomonocytic, Chronic 20 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Burkitt Lymphoma 20 Lymphoma, Large-Cell, Immunoblastic 19 Leukemia, Myeloid, Accelerated Phase 19 Blast Crisis 19 Myeloproliferative Disorders 18 Leukemia, Myeloid, Chronic-Phase 18 Primary Myelofibrosis 16 Hematologic Neoplasms 14 Graft vs Host Disease 13 Lymphoma, T-Cell, Cutaneous 12 Dendritic Cell Sarcoma, Interdigitating 12 Myelodysplastic-Myeloproliferative Diseases 11 Anemia, Refractory, with Excess of Blasts 11

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡